Plain-English translation of NCT04863950 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Glioblastoma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether and —two medications—used together can help treat glioblastoma (an aggressive brain cancer) that has come back after initial radiation and chemotherapy. Researchers want to see if this medication combination can help people whose cancer did not respond to or has progressed past standard treatment. The study will include up to 25 people and is taking place at one medical center.
Glioblastoma is a very serious brain cancer, and when it returns after standard treatment, options are limited. This trial is exploring whether this medication combination might offer a new way to treat people in this difficult situation.
You likely qualify if…
You likely don't qualify if…
If you are accepted into this trial, you will receive the two medications as part of your cancer treatment. You may be in either a surgical or non-surgical group depending on your situation. You will have regular visits for medical exams, blood tests, and imaging scans (like MRIs) to check how the treatment is working and monitor for side effects. The exact schedule and duration will be discussed with the research team, but you should expect ongoing appointments to track your progress.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
United States